Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
37.00
-1.26 (-3.29%)
At close: Apr 28, 2026
-40.73%
Market Cap 296.07M
Revenue (ttm) 483.98M
Net Income (ttm) -12.81M
Shares Out 7.79M
EPS (ttm) -1.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 533
Average Volume 11,342
Open 37.50
Previous Close 38.26
Day's Range 37.00 - 37.50
52-Week Range 29.00 - 68.40
Beta 0.83
RSI 51.55
Earnings Date May 26, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporate... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.